These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38628789)

  • 1. Novel ACC Inhibitors for Treating Acne.
    Sabnis RW
    ACS Med Chem Lett; 2024 Apr; 15(4):445-446. PubMed ID: 38628789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Compounds as TEAD Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Sep; 14(9):1152-1153. PubMed ID: 37736181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma.
    Sabnis RW
    ACS Med Chem Lett; 2023 Oct; 14(10):1336-1337. PubMed ID: 37849559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Oct; 14(10):1334-1335. PubMed ID: 37849539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 May; 14(5):555-556. PubMed ID: 37197476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jun; 14(6):707-708. PubMed ID: 37312857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):775-776. PubMed ID: 38894910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):748-749. PubMed ID: 38894901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Aug; 15(8):1184-1185. PubMed ID: 39140065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Aug; 14(8):1045-1046. PubMed ID: 37583830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jul; 15(7):994-995. PubMed ID: 39015277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):777-778. PubMed ID: 38894904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Furopyridine and Furopyrimidine Compounds as PI4K Inhibitors for Treating Malaria and Viral Infection.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):779-780. PubMed ID: 38894915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel PARP1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Feb; 15(2):161-162. PubMed ID: 38352834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel PARP7 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Dec; 14(12):1615-1616. PubMed ID: 38116422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel PARP1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Dec; 14(12):1629-1630. PubMed ID: 38116419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel CD73 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 May; 15(5):571-572. PubMed ID: 38746902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel IL4I1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jun; 14(6):700-701. PubMed ID: 37312856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Phosphorylpurinone Compounds for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Apr; 15(4):441-442. PubMed ID: 38628787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Feb; 15(2):177-178. PubMed ID: 38352847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.